17 results on '"Muthigi, Akhil"'
Search Results
2. ORAL PREDNISONE AS A RESCUE INTERVENTION FOR DETERIORATING SPERM PARAMETERS FOLLOWING VASOVASOSTOMY.
- Author
-
Deebel, Nicholas, Muthigi, Akhil, White, Joshua Theodore, Campbell, Katherine, Egemba, Christabel, Campos, Lucas R., and Ramasamy, Ranjith
- Subjects
- *
SPERMATOZOA , *PREDNISONE - Published
- 2023
- Full Text
- View/download PDF
3. Clarifying the relationship between total motile sperm counts and intrauterine insemination pregnancy rates.
- Author
-
Muthigi, Akhil, Jahandideh, Samad, Bishop, Lauren A., Naeemi, Firoozeh K., Shipley, Sharon K., O'Brien, Jeanne E., Shin, Paul R., Devine, Kate, and Tanrikut, Cigdem
- Subjects
- *
SPERM count , *GENERALIZED estimating equations , *PREGNANCY , *BODY mass index , *FERTILITY clinics - Abstract
Objective: To study the relationship between postwash total motile sperm count (TMSC) and intrauterine insemination (IUI) outcomes.Design: Retrospective review SETTING: Large fertility clinic PATIENT(S): A total of 92,471 insemination cycles from 37,553 patients were included in this study.Intervention(s): All stimulated clomiphene citrate, letrozole, and/or injectable gonadotropin IUI cycles performed at a single institution from 2002 through 2018 were reviewed. Generalized estimating equations (GEE) analysis was used to account for multiple cycles by individual patients and to adjust for female partner age, body mass index, and stimulation protocol.Main Outcome Measure(s): Successful clinical pregnancy was defined as ultrasound confirmation of an intrauterine gestational sac with fetal cardiac activity.Result(s): A total of 92,471 insemination cycles were available to evaluate the relationship between postwash TMSC and clinical pregnancy. Pregnancy rates were highest with TMSC of ≥9 × 106 and declined gradually as TMSC decreased. Complete data for the adjusted GEE analysis were available for 62,758 cycles. Adjusted GEE analysis among cycles with TMSC of ≥9 × 106 (n = 46,557) confirmed that TMSC in this range was unrelated to pregnancy. Conversely, TMSC was highly predictive of pregnancy (Wald χ2 = 39.85) in adjusted GEE analysis among cycles with TMSC of <9 × 106 (n = 16,201), with a statistically significant decline.Conclusions: IUI pregnancy is optimized with TMSC of ≥9 × 106, below which the rates gradually decline. Although rare, pregnancies were achieved with TMSC of <0.25 × 106. Since the decline in pregnancy is gradual and continuous, there is no specific threshold above which IUI should be recommended. Rather, these more specific quantitative predictions can be used to provide personalized counseling and guide clinical decision making. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
4. Management of Scrotal Nodules.
- Author
-
Codrington, Jason, Cromar, Zachary, Muthigi, Akhil, White, Joshua, and Ramasamy, Ranjith
- Published
- 2023
- Full Text
- View/download PDF
5. The use of dual growing rods to correct spinal deformity secondary to a low-grade spinal cord astrocytoma.
- Author
-
Kuhn, Elizabeth N., Muthigi, Akhil, Frino, John, and Powers, Alexander K.
- Subjects
- *
ASTROCYTOMAS , *SPINAL cord , *RADIOTHERAPY - Abstract
Pediatric intramedullary spinal cord astrocytomas are rare, and the majority are low grade, typically carrying a low risk of mortality, but a high risk of morbidity. Quality of life is, therefore, an important consideration in treating concomitant progressive kyphoscoliosis. Compared with fusion-based spinal stabilization, fusionless techniques may limit some complications related to early instrumentation of the developing spine. Another consideration is the timing of radiation therapy relative to both spinal maturity and spinal instrumentation. To date, there have been no reports of the use of a fusionless technique to treat spinal deformity secondary to an intramedullary spinal cord tumor. Herein, we report the use of fusionless spinal stabilization with dual growing rods in a boy with low-grade spinal cord astrocytoma after radiation therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. CLARIFYING THE RELATIONSHIP BETWEEN TOTAL MOTILE SPERM COUNTS (TMSC) AND INTRAUTERINE INSEMINATION (IUI) PREGNANCY RATES.
- Author
-
Muthigi, Akhil, Jahandideh, Samad, Bishop, Lauren A., Naeemi, Firoozeh K., Shipley, Sharon K., O'Brien, Jeanne E., Shin, Paul, Devine, Kate, and Tanrikut, Cigdem
- Subjects
- *
SPERM count , *PREGNANCY - Published
- 2020
- Full Text
- View/download PDF
7. Fertility outcomes in men with prior history of anabolic steroid use.
- Author
-
Ledesma, Braian R., Weber, Alexander, Venigalla, Greeshma, Muthigi, Akhil, Thomas, Jamie, Narasimman, Manish, White, Joshua, and Ramasamy, Ranjith
- Subjects
- *
HUMAN fertility , *ANABOLIC steroids , *OLIGOSPERMIA , *STEROID drugs , *REPRODUCTIVE technology , *MALE infertility , *CHORIONIC gonadotropins - Abstract
To study sperm parameters recovery and fertility outcomes in men with azoospermia or severe oligospermia caused by anabolic steroid use who underwent a standardized treatment regimen for spermatogenesis recovery. A retrospective analysis of a cohort of men with a prior history of anabolic steroid use and infertility complaints (between 2018 and 2022) was conducted. The standardized treatment approach involved discontinuing testosterone replacement therapy and administering a combination regimen of clomiphene citrate and human chorionic gonadotropin for a minimum of 3 to 6 months. The main outcome measures included changes in sperm parameters, predominantly sperm concentration, and subsequent pregnancy outcomes. A total of 45 men (median age 37 years, IQR 32–45) met the inclusion criteria for this analysis. Median duration of prior T use was 4 years (IQR 1.3–10), with the 2 most common modalities consisting of injection therapy (43.5%) and oral therapy (34.8%). The median initial sperm concentration was 0 million/cc (IQR 0–1.15), and 23 (51.1%) men initially presented with azoospermia. The median duration of combination human chorionic gonadotropin/clomid therapy was 5 months (IQR 3–12). In initially azoospermic men (N: 23), 5 were lost to follow-up, 6 (33.3%) progressed to severe oligospermia (<5 million/cc), 6 (33.3%) to oligospermia (<15 million/cc), 1 (5.6%) to normozoospermia (>15 million/cc), and 5 (27.8%) remained azoospermic after medical treatment for 6 months. Among the 24 couples who responded to the follow-up call, a total of 9 (37.5%) achieved a successful subsequent pregnancy. Of these, 33.3% (3 couples) used assisted reproductive technology, whereas 66.7% (6 couples) conceived naturally. On logistic regression analysis, no significant predictors for improved sperm parameters or successful pregnancy were identified. Despite appropriate treatment regimens, a significant proportion of men with a prior history of anabolic steroid use continue to exhibit severe oligospermia, with more than half showing limited improvement in semen parameters after 6 months of treatment. Only a fraction of men achieves normozoospermia after treatment. Further research is needed to explore predictors for improved sperm parameters and successful pregnancy outcomes in men with a history of anabolic steroid use. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Primer on Female Infertility for the Reproductive Urologist.
- Author
-
Dullea, Matthew, Mouhanna, Joelle, Marquez, Kyara, Muthigi, Akhil, Ledesma, Braian, White, Joshua, and Ramasamy, Ranjith
- Subjects
- *
OCCUPATIONAL roles , *ENDOMETRIOSIS , *TISSUE adhesions , *COUNSELING , *POLYCYSTIC ovary syndrome , *ANOVULATION , *UTERINE diseases , *UTERINE fibroids , *INFERTILITY , *UROLOGISTS , *OVARIAN reserve , *HUMAN reproductive technology , *PHYSICIANS , *DECISION making in clinical medicine , *WOMEN'S health , *REPRODUCTIVE health , *DISEASE complications ,FALLOPIAN tube diseases - Abstract
This review is intended to serve as an aid in decision-making and patient counseling for the reproductive urologist when female factor infertility is found concurrently with male factor infertility. This review pairs the pathophysiology of female infertility with its implications for the treatment of male infertility, which most commonly includes ovulatory disorders, tubal abnormalities, and uterine abnormalities. By gaining a deeper understanding of these factors, reproductive urologists can employ a tailored approach to managing male factor infertility, taking into account the female partner's specific medical history. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
- Author
-
Muthigi, Akhil, Sidana, Abhinav, George, Arvin K., Kongnyuy, Michael, Maruf, Mahir, Valayil, Subin, Wood, Bradford J., and Pinto, Peter A.
- Subjects
- *
PROSTATE , *PROSTATE biopsy , *DIAGNOSIS , *PROSTATE cancer , *PROSTATECTOMY , *MEDICAL statistics , *MAGNETIC resonance imaging , *ACADEMIC medical centers , *ATTITUDE (Psychology) , *BIOPSY , *COMPARATIVE studies , *DIAGNOSTIC imaging , *HEALTH services accessibility , *RESEARCH methodology , *MEDICAL cooperation , *MEDICAL personnel , *PROSTATE tumors , *RESEARCH , *RESEARCH funding , *ULTRASONIC imaging , *PROFESSIONAL practice , *EVALUATION research , *PATIENT selection , *ECONOMICS - Abstract
Introduction and Objective: Multiparametric magnetic resonance imaging (MRI) and magnetic resonance (MR) -targeted biopsy have a growing role in the screening and evaluation of prostate cancer. We aim to evaluate the current knowledge, attitude, and practice patterns of urologists regarding this new technique.Methods: An anonymous online questionnaire was designed to collect information on urologists' beliefs and use of prostate multiparametric MRI and MR-targeted biopsy. The survey was sent to members of the Society of Urologic Oncology, the Endourological Society, and European Association of Urology. Multivariate logistic regression analysis was performed to determine predictors for use of prostate MRI and MR-targeted biopsy.Results: A total of 302 responses were received (Endourological Society: 175, European Association of Urology: 23, and Society of Urologic Oncology: 104). Most respondents (83.6%) believe MR-targeted biopsy to be moderately to extremely beneficial in the evaluation of prostate cancer. Overall, 85.7% of responders use prostate MRI in their practice, and 63.0% use MR-targeted biopsy. The 2 most common settings for use of MR-targeted biopsy include patients with history of prior negative biopsy result (96.3%) and monitoring patients on active surveillance (72.5%). In those who do not use MR-targeted biopsy, the principal reasons were lack of necessary infrastructure (64.1%) and prohibitive costs (48.1%). On multivariate logistic regression analysis, practice in an academic setting (1.86 [1.02-3.40], P = 0.043) and performing greater than 25 radical prostatectomies per year (2.32 [1.18-4.56], P = 0.015) remained independent predictors for using MR-targeted biopsy.Conclusions: Most respondents of our survey look favorably on use of prostate MRI and MR-targeted biopsy in clinical practice. Over time, reduction in fixed costs and easier access to equipment may lead to further dissemination of this novel and potentially transformative technology. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
10. PATIENT SATISFACTION AFTER SWITCHING TO ORAL TESTOSTERONE UNDECANOATE IN MEN CURRENTLY RECEIVING TESTOSTERONE THERAPY: AN OPEN-LABEL SINGLE-CENTER PHASE IV CLINICAL TRIAL.
- Author
-
Reddy, Rohit, Patel, Mehul S., Muthigi, Akhil, and Ramasamy, Ranjith
- Subjects
- *
PATIENT satisfaction , *TESTOSTERONE , *CLINICAL trials - Published
- 2022
- Full Text
- View/download PDF
11. LONG-TERM EVALUATION OF SPERM PARAMETERS FOLLOWING COVID-19 mRNA VACCINATION.
- Author
-
Diaz, Parris, Dullea, Alexandra, Patel, Mehul S., Blachman-Braun, Ruben, Reddy, Rohit, Khodamoradi, Kajal, Ibrahim, Emad, Bidhan, Joginder, Muthigi, Akhil, and Ramasamy, Ranjith
- Subjects
- *
COVID-19 vaccines , *SPERMATOZOA - Published
- 2022
- Full Text
- View/download PDF
12. A urologist's perspective on prostate cancer imaging: past, present, and future.
- Author
-
George, Arvin, Turkbey, Baris, Valayil, Subin, Muthigi, Akhil, Mertan, Francesca, Kongnyuy, Michael, and Pinto, Peter
- Subjects
- *
UROLOGISTS , *PROSTATE cancer , *DIAGNOSIS , *MEDICAL imaging systems , *ULTRASONIC imaging , *BIOPSY - Abstract
Prostate cancer is unique in that unlike other solid organ malignancies, only recently has imaging been employed to routinely detect and localize disease. The introduction of transrectal ultrasound was a significant development, transitioning digitally guided prostate biopsies to ultrasound guidance. The arrival of multiparametric MRI has become the next major step, transforming the way Urologist's diagnose, stage, and treat prostate cancer. Recent recommendations against PSA screening have changed the landscape of urologic oncology with the changing needs being reflected in the initiation of additional robust imaging techniques at different time points in prostate cancer care. The current review aims to provide a clinical perspective in the history, current standard of care, and novel imaging modalities in the evaluation of prostate cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis.
- Author
-
Kongnyuy, Michael, Frye, Thomas, George, Arvin K., Kilchevsky, Amichai, Iyer, Amogh, Kadakia, Meet, Muthigi, Akhil, Turkbey, Baris, Wood, Brad J., and Pinto, Peter A.
- Subjects
- *
COLITIS treatment , *ULCERATIVE colitis , *MAGNETIC resonance imaging , *RESTORATIVE proctocolectomy , *SURGICAL anastomosis , *ENDORECTAL ultrasonography , *GASTROENTEROLOGISTS , *PROSTATE biopsy , *DIGITAL rectal examination - Abstract
Ulcerative colitis (UC) is an inflammatory disease that specifically affects the colon. Ulcerative colitis is primarily treated medically and refractory disease is treated with proctocolectomy and ileal pouch-anal anastomosis (IPAA). Gastroenterologists advise against digital rectal exams, pelvic radiation therapy, and transrectal ultrasound (TRUS) biopsies of the prostates of ileal pouch-anal anastomosis patients. Any form of pouch manipulation can lead to severe bleeding, inflammation, and pain. Urologists are therefore faced with the challenge of doing a prostate biopsy without a transrectal ultrasound. We report the rare case of a patient with an ileal pouch-anal anastomosis who underwent in-bore transperineal MRI-guided biopsy of the prostate. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.
- Author
-
Sidana, Abhinav, Watson, Matthew J., George, Arvin K., Rastinehad, Ardeshir R., Vourganti, Srinivas, Rais-Bahrami, Soroush, Muthigi, Akhil, Maruf, Mahir, Gordetsky, Jennifer B., Nix, Jeffrey W., Merino, Maria J., Turkbey, Baris, Choyke, Peter L., Wood, Bradford J., and Pinto, Peter A.
- Subjects
- *
PROSTATE biopsy , *PROSTATE-specific antigen , *COHORT analysis , *MAGNETIC resonance imaging , *GLEASON grading system , *LOGISTIC regression analysis , *BIOPSY , *COMPARATIVE studies , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *NEEDLE biopsy , *PROSTATE tumors , *RESEARCH , *EVALUATION research , *RETROSPECTIVE studies , *TUMOR grading , *DIAGNOSIS - Abstract
Introduction and Objectives: Patients with persistently elevated prostate specific antigen (PSA) and prior negative 12-core TRUS prostate biopsy (or biopsies) (systematic biopsy-SBx) are a diagnostic challenge. Repeat SBx or saturation biopsy in this cohort has been shown to have an even lower yield. The aim of our study is to compare the prostate cancer yield of magnetic resonance imaging (MRI) fusion biopsy (FBx) to SBx in a multi-institutional cohort comprised of patients with prior negative biopsies.Methods: A multi-institutional review was performed on patients with a history of one or more prior negative SBx who underwent multiparametric MRI (mpMRI), followed by FBx and SBx in the same session. Imaging protocol was standardized across institutions and institutional genitourinary radiologists and pathologists reviewed mpMRI and pathology, respectively. Gleason score (GS) distribution and risk classifications were recorded. Prostate cancer with GS ≥3 + 4 was defined as clinically significant (CS). Univariate and multivariable logistic regression was done to identify predictors of cancer detection on SBx and FBx.Results: Seven-hundred seventy-nine patients from four institutions were included in the study. Median age and prostate specific antigen (IQR) were 63.1 (58.5-68.0) years and 8.5 (5.9-13.1)ng/dl, respectively. Median number of prior negative biopsies (range) was 2.0 (1-16). The cancer detection rate (CDR) in the cohort was 346/779 patients (44.4%). Total CS CDR was 30.7% (239/779 patients), with FBx detecting 26.3% (205/779) of patients with CS disease and SBx diagnosing an additional 4.4% (34/779) of patients (P<0.001). Furthermore, of all cancers detected by each modality, FBx detected a higher proportion of CS cancer compared to SBx (one negative biopsy: 75 vs. 50%, P<0.001, 2-3 negative biopsy: 76 vs. 61%, P = 0.006, 4 or more negative biopsies: 84 vs. 52%, P = 0.006). As such, SBx added a relatively small diagnostic value to FBx for detecting CS disease (one negative biopsy 3.5%, 2-3 negative biopsies 5%, 4 or more negative biopsies: 1%). FBx also outperformed SBx for upgrading patients to an intermediate or high-risk cancer category (GS>6) (one negative biopsy 11.5% vs. 3.6%, 2-3 negative biopsy 10.3% vs. 5.3%, 4 or more negative biopsies 19.1% vs. 1.1%). On multivariable analysis, the number of prior negative biopsies was a significant negative predictor of CS CDR on SBx (P = 0.006), but not on FBx (P = 0.151).Conclusions: Using a large multi-institutional cohort, we were able to demonstrate that FBx outperformed SBx in patients with prior negative systematic biopsy. This was due, in part, to the decreasing CS CDR by SBx with increased number of prior biopsies. The yield of FBx stayed constant and did not decrease with increased number of prior negative biopsies. Therefore, repeat SBx alone in patients with multiple prior negative biopsies will be hindered by lower yield and FBx should be utilized concurrently in these patients. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
15. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
- Author
-
Kongnyuy, Michael, Sidana, Abhinav, George, Arvin K., Muthigi, Akhil, Iyer, Amogh, Ho, Richard, Chelluri, Raju, Mertan, Francesca, Frye, Thomas P., Su, Daniel, Merino, Maria J., Choyke, Peter L., Wood, Bradford J., Pinto, Peter A., and Turkbey, Baris
- Subjects
- *
PROSTATE , *BIOMARKERS , *DIAGNOSIS , *PROSTATE cancer , *CANCER relapse , *PROSTATECTOMY , *MAGNETIC resonance imaging - Abstract
Background: The high-spatial resolution of multiparametric magnetic resonance imaging (mpMRI) has improved the detection of clinically significant prostate cancer. mpMRI characteristics (extraprostatic extension [EPE], number of lesions, etc.) may predict final pathological findings (positive lymph node [pLN] and pathological ECE [pECE]) and biochemical recurrence (BCR). Tumor contact length (TCL) on MRI, defined as the length of a lesion in contact with the prostatic capsule, is a novel marker with promising early results. We aimed to evaluate TCL as a predictor of +pathological EPE (+pEPE),+pathological LN (+pLN), and BCR in patients undergoing robotic-assisted laparoscopic radical prostatectomy.Materials and Methods: A review was performed of a prospectively maintained single-institution database of men with prostate cancer who underwent prostate mpMRI followed by robotic-assisted laparoscopic radical prostatectomy without prior therapy from 2007 to 2015. TCL was measured using T2-weighted magnetic resonance images. Logistic and Cox regression analysis were used to assess associations of clinical, imaging, and histopathological variables with pEPE, pLN, and BCR. Receiver operating characteristic curves were used to characterize and compare TCL performance with Partin tables.Results: There were 87/379 (23.0%)+pEPE, 18/384 (4.7%)+pLN, and 33/371 (8.9%) BCR patients. Patients with adverse pathology/oncologic outcomes had longer TCL compared to those without adverse outcomes (+pEPE: 19.8 vs. 10.1mm, P<0.0001,+pLN: 38.0 vs. 11.7mm, P<0.0001, and BCR: 19.2 vs. 11.2mm, P = 0.001). On multivariate analysis, TCL remained a predictor of+pEPE (odds ratio: 1.04, P = 0.001),+pLN (odds ratio: 1.07, P<0.0001), and BCR (hazard ratio: 1.03, P = 0.02). TCL thresholds for predicting+pEPE and+pLN were 12.5 and 19.7mm, respectively. TCL alone was found to have good predictive ability for+pEPE and+PLN (pEPE:TCLAUC: 0.71 vs. PartinAUC: 0.66, P = 0.21; pLN:TCLAUC: 0.77 vs. PartinAUC: 0.88, P = 0.04).Conclusion: We demonstrate that TCL is an independent predictor of+pEPE, +pLN, and BCR. If validated, this imaging biomarker may facilitate and inform patient counseling and decision-making. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
16. Corrigendum to “A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis”.
- Author
-
Kongnyuy, Michael, Frye, Thomas, George, Arvin K., Kilchevsky, Amichai, Iyer, Amogh, Kadakia, Meet, Muthigi, Akhil, Turkbey, Baris, Wood, Bradford J., and Pinto, Peter A.
- Subjects
- *
PROSTATE biopsy , *PROSTATE , *SURGICAL anastomosis , *MAGNETIC resonance imaging - Published
- 2016
- Full Text
- View/download PDF
17. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.
- Author
-
Kongnyuy, Michael, Sidana, Abhinav, George, Arvin K., Muthigi, Akhil, Iyer, Amogh, Fascelli, Michele, Kadakia, Meet, Frye, Thomas P., Ho, Richard, Mertan, Francesca, Minhaj Siddiqui, M., Su, Daniel, Merino, Maria J., Turkbey, Baris, Choyke, Peter L., Wood, Bradford J., and Pinto, Peter A.
- Subjects
- *
PROSTATE cancer treatment , *PROSTATE cancer , *AFRICAN American men , *ENDORECTAL ultrasonography , *PROSTATECTOMY , *COHORT analysis , *GLEASON grading system , *DISEASES , *MAGNETIC resonance imaging - Abstract
Introduction: African-American (AA) men tend to harbor high-risk prostate cancer (PCa) and exhibit worse outcomes when compared to other groups. It has been postulated that AA men may harbor more anterior prostate lesions (APLs) that are undersampled by the standard transrectal ultrasound guided-biopsy (SBx), potentially resulting in greater degree of Gleason score (GS) upgrading at radical prostatectomy. We aimed to evaluate the detection rate of anterior PCa significance of APLs in AA men on multiparametric magnetic resonance imaging (mpMRI) and compare it to a matched cohort of White/Other (W/O) men.Materials and Methods: A review of 1,267 men who had an mpMRI with suspicious prostate lesions and who underwent magnetic resonance transrectal ultrasound fusion-guided biopsy (FBx) with concurrent SBx in the same biopsy session was performed. All AA men were matched to a control group of W/O using a 1:1 propensity score-matching algorithm with age, prostate-specific antigen, and prostate volume as matching variables. Logistic regression analysis was used to determine predictors of APLs in AA men.Results: Of the 195 AA men who underwent mpMRI, 93 (47.7%) men had a total of 109 APLs. Prior negative SBx was associated with the presence of APLs in AA men (Odds ratio = 1.81; 95% CI: 1.03-3.20; P = 0.04). On multivariate logistic regression analysis, smaller prostate (P = 0.001) and rising prostate-specific antigen (P = 0.007) were independent predictors of cancer-positive APLs in AA men. Comparative analysis of AA (93/195, 47.7%) vs. W/O (100/194, 52%) showed no difference in the rates of APLs (P = 0.44) or in cancer detection rate within those lesions or the distribution of GS within those cancers (P = 0.63) despite an overall higher cancer detection rate in AA men (AA: 124/195 [63.6%] vs. W/O: 97/194 [50.0%], P = 0.007). In cases where APLs were positive for PCa on FBx, the GS of APL was equal to the highest GS of the entire gland in 82.9% (29/35) and 90.9% (30/33) of the time in AA and W/O men, respectively.Conclusion: Cancer-positive APLs represented the highest risk GS in most cases. AA men with prior negative SBx are twice as likely to harbor a concerning APL. In our cohort, AA and W/O men had comparable rates of APLs on mpMRI. Thus, differences in APLs do not explain the higher risk of AA men for deahth due to PCa. However, targeting of APLs via FBx can clinically improve PCa risk stratification and guide appropriate treatment options. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.